Clinical and morphological aspects of neoadjuvant chemotherapy efficacy in patients with aggressive luminal HER2-negative breast cancer
Background. The role of neoadjuvant chemotherapy (NACT) in luminal HER2-negative breast cancer (BC) remains highly controversial due to the lack of reliable predictors of drug therapy efficacy.Objective: to evaluate the effectiveness of NACT in patients with aggressive luminal HER2-negative BC and t...
Saved in:
| Main Authors: | D. A. Morozov, I. V. Kolyadina, I. V. Poddubnaya, I. P. Ganshina, S. V. Khokhlova, V. V. Kometova, V. V. Rodionov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-01-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/894 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
by: Naing Lin Shan, et al.
Published: (2024-12-01) -
Study on heterogeneity of vascularity and cellularity via multiparametric MRI habitat imaging in breast cancer
by: Xiaolei Zhang, et al.
Published: (2025-05-01) -
STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
by: A. N. Stukov, et al.
Published: (2019-11-01) -
Disaggregation of luminal alimentary tract tumors by E-cad disruption: a report of six cases
by: Man Li, et al.
Published: (2025-08-01) -
Key studies that have changed the history and treatment of early HER2+ breast cancer: focus on individual therapy
by: I. V. Kolyadina, et al.
Published: (2021-01-01)